BIOEMTECH is a fast-growing Greek SME in the field of biomedical engineering, providing solutions both in terms of instrumentation and services, in preclinical research. The company designs and develops desktop in vivo molecular imaging systems and provides full preclinical CRO services for the evaluation of nanoparticles and other novel compounds. In addition, BIOEMTECH offers unique expertise in terms of advanced simulations at multiscale level, Artificial Intelligence algorithms, and exploitation of realistic computational models. BIOEMTECH Laboratories provide preclinical services that cover a wide range of studies, from an in vitro level, to radiochemistry, animal hosting, toxicology, and multi-modal in vivo imaging using SPECT, PET, CT, and Optical preclinical imaging systems. The company was founded in 2013 and up to now participated in 9 H2020, 4 ERANET (European), and 3 NSRF (national) research projects, as well as 2 COST Actions. BIOEMTECH is a multidisciplinary team of young scientists with a strong background in biomedical engineering, radiochemistry, biology, nanomedicine, medical physics, and bioinformatics. There is a big network of collaborators as the company officially participates in ETPN, EARA, and OpenGATE networks.